ATE227131T1 - Orale zusammenstellung die 5-aminosalicylsäure enthält - Google Patents

Orale zusammenstellung die 5-aminosalicylsäure enthält

Info

Publication number: ATE227131T1
Authority: AT; Austria
Prior art keywords: oral; aminosalicylic acid; ulcers; composition containing; oral composition
Prior art date: 1996-08-13

Application number

AT97918973T

Other languages

English (en)

Inventor

Thomas Buser

Original Assignee

Tillotts Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-13

Filing date

1997-08-12

Publication date

2002-11-15

1997-08-12 Application filed by Tillotts Pharma Ag filed Critical Tillotts Pharma Ag

2002-11-15 Application granted granted Critical

2002-11-15 Publication of ATE227131T1 publication Critical patent/ATE227131T1/de

Links

KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 title abstract 3
229960004963 mesalazine Drugs 0.000 title abstract 3
208000025865 Ulcer Diseases 0.000 abstract 2
230000003902 lesion Effects 0.000 abstract 2
231100000397 ulcer Toxicity 0.000 abstract 2
RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 abstract 1
206010061218 Inflammation Diseases 0.000 abstract 1
208000007117 Oral Ulcer Diseases 0.000 abstract 1
208000005522 Orofacial Granulomatosis Diseases 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
229940074096 monoolein Drugs 0.000 abstract 1
210000000214 mouth Anatomy 0.000 abstract 1
208000014996 oral Crohn disease Diseases 0.000 abstract 1
206010030983 oral lichen planus Diseases 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)

AT97918973T 1996-08-13 1997-08-12 Orale zusammenstellung die 5-aminosalicylsäure enthält ATE227131T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9617001.4A GB9617001D0 (en)	1996-08-13	1996-08-13	Oral composition
PCT/EP1997/004376 WO1998006387A2 (en)	1996-08-13	1997-08-12	Oral composition comprising 5-aminosalicylic acid

Publications (1)

Publication Number	Publication Date
ATE227131T1 true ATE227131T1 (de)	2002-11-15

Family

ID=10798432

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97918973T ATE227131T1 (de)	1996-08-13	1997-08-12	Orale zusammenstellung die 5-aminosalicylsäure enthält

Country Status (12)

Country	Link
US (1)	US6217897B1 (de)
EP (1)	EP0951287B1 (de)
JP (1)	JP4597273B2 (de)
AT (1)	ATE227131T1 (de)
AU (1)	AU4298597A (de)
CA (1)	CA2263070C (de)
DE (1)	DE69716947T2 (de)
DK (1)	DK0951287T3 (de)
ES (1)	ES2188933T3 (de)
GB (1)	GB9617001D0 (de)
PT (1)	PT951287E (de)
WO (1)	WO1998006387A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0001449D0 (en) *	2000-01-21	2000-03-08	Cortendo Ab	Compositions
CA2436139A1 (en) *	2001-01-26	2002-08-01	Emory University	Methods of inducing organ transplant tolerance and correcting hemoglobinopathies
EP1474159B1 (de) *	2002-02-08	2007-04-11	JOHNSON & JOHNSON GmbH	Zusammensetzungen mit haferstroh und weidekraut-extrakt
KR100533460B1 (ko) *	2002-07-20	2005-12-08	대화제약 주식회사	난용성 약물의 가용화용 점막흡착성 조성물, 이를 이용한난용성 약물의 가용화용 제형 및 이들의 제조 방법
JP4669960B2 (ja) *	2003-06-03	2011-04-13	株式会社メドレックス	局所麻酔薬を含有する口中用または咽頭部用製剤
US20060127437A1 (en) *	2004-12-13	2006-06-15	Misty Anderson Kennedy	Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US20070059350A1 (en) *	2004-12-13	2007-03-15	Kennedy John P	Agents for controlling biological fluids and methods of use thereof
US8535709B2 (en) *	2004-12-13	2013-09-17	Southeastern Medical Technologies, Llc	Agents for controlling biological fluids and methods of use thereof
ITRM20050389A1 (it)	2005-07-22	2007-01-23	Giuliani Spa	Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
ITRM20050390A1 (it)	2005-07-22	2007-01-23	Giuliani Spa	Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
IE20070129A1 (en) *	2007-02-28	2008-12-24	Giuliani Int Ltd	Ppar-gamma agonists stimulate enteric defensin expression
UA107562C2 (uk)	2008-12-05	2015-01-26		Спосіб лікування псоріазу
WO2010091894A2 (en)	2009-02-16	2010-08-19	Giuliani International Limited	Methods of treating hair related conditions
US20140030354A1 (en) *	2011-03-09	2014-01-30	Paul F. Reid	Composition and method for oral delivery of cobra venom
CN109999017A (zh)	2012-02-09	2019-07-12	诺格拉制药有限公司	治疗纤维化的方法
CN104284655B (zh)	2012-04-18	2017-10-27	诺格拉制药有限公司	治疗乳糖不耐受的方法
CN102697937A (zh) *	2012-06-28	2012-10-03	王佳丽	一种治疗口腔溃疡的药物及其制备方法
RU2540493C1 (ru) *	2013-12-10	2015-02-10	Гюзель Маратовна Акмалова	Способ местного лечения красного плоского лишая слизистой оболочки полости рта типичной формы
EP4495101A3 (de)	2019-02-08	2025-04-30	Nogra Pharma Limited	Verfahren zur herstellung von 3-(4'-aminophenyl)-2-methoxypropionsaure, sowie analoge uno zwischenprodukte davon
CN113350277A (zh) *	2021-06-30	2021-09-07	广东科伦药业有限公司	一种治疗化疗口腔黏膜炎的美沙拉秦含漱液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE68919009T2 (de)	1988-05-05	1995-02-23	Tillotts Pharma Ag	Verwendung von 5-Amino-salicylsäure für die Behandlung von Hautkrankheiten.
DK254289D0 (da)	1989-05-25	1989-05-25	Dumex Ltd As	Middel til behandling af svampeinfektioner
US5262164A (en)	1989-11-17	1993-11-16	The Procter & Gamble Company	Sustained release compositions for treating periodontal disease
NL9000237A (nl) *	1990-01-31	1991-08-16	Re Novative Drugs For Dermatol	Topicale farmaceutische composities voor de mondholte en vagina.
ATE180971T1 (de)	1994-03-30	1999-06-15	Gs Dev Ab	Verwendung von fettsäureester als bioklebstoffe

1996
- 1996-08-13 GB GBGB9617001.4A patent/GB9617001D0/en active Pending
1997
- 1997-08-12 DK DK97918973T patent/DK0951287T3/da active
- 1997-08-12 DE DE69716947T patent/DE69716947T2/de not_active Expired - Lifetime
- 1997-08-12 CA CA002263070A patent/CA2263070C/en not_active Expired - Fee Related
- 1997-08-12 AT AT97918973T patent/ATE227131T1/de active
- 1997-08-12 AU AU42985/97A patent/AU4298597A/en not_active Abandoned
- 1997-08-12 US US09/147,631 patent/US6217897B1/en not_active Expired - Fee Related
- 1997-08-12 ES ES97918973T patent/ES2188933T3/es not_active Expired - Lifetime
- 1997-08-12 WO PCT/EP1997/004376 patent/WO1998006387A2/en not_active Ceased
- 1997-08-12 JP JP50940098A patent/JP4597273B2/ja not_active Expired - Fee Related
- 1997-08-12 EP EP97918973A patent/EP0951287B1/de not_active Expired - Lifetime
- 1997-08-12 PT PT97918973T patent/PT951287E/pt unknown

Also Published As

Publication number	Publication date
PT951287E (pt)	2003-03-31
DE69716947D1 (de)	2002-12-12
GB9617001D0 (en)	1996-09-25
WO1998006387A2 (en)	1998-02-19
WO1998006387A3 (en)	1998-03-19
JP4597273B2 (ja)	2010-12-15
CA2263070A1 (en)	1998-02-19
JP2000516227A (ja)	2000-12-05
EP0951287A2 (de)	1999-10-27
US6217897B1 (en)	2001-04-17
ES2188933T3 (es)	2003-07-01
DK0951287T3 (da)	2002-12-09
EP0951287B1 (de)	2002-11-06
CA2263070C (en)	2009-09-08
AU4298597A (en)	1998-03-06
DE69716947T2 (de)	2003-07-17

Legal Events

Date

Code

Title

Description

2003-04-15

UEP

Publication of translation of european patent specification

Ref document number: 0951287

Country of ref document: EP

Publication	Publication Date	Title
ATE227131T1 (de)	2002-11-15	Orale zusammenstellung die 5-aminosalicylsäure enthält
RU93047799A (ru)	1996-03-20	Композиции, содержащие ретиноевые кислоты и токоферол
IL154693A (en)	2010-04-15	Use of testosterone gel to make a remedy for testosterone deficiency in women
RU93005355A (ru)	1995-09-27	Фармакологические композиции
ATE187887T1 (de)	2000-01-15	Verzögerte freigabe matrix für arzneimittel
ATE126055T1 (de)	1995-08-15	Naproxen-formulierung zur kontrollierten absorption zur einmal täglichen anwendung.
EP2039355A3 (de)	2012-02-01	Oberflächliche Verwendung von Valproinsäure zur Vorbeugung oder Behandlung von Hauterkrankungen
NO923809D0 (no)	1992-09-30	Farmasoeytisk preparat
CA2215329A1 (en)	1996-09-19	Colorectal chemoprotective composition and method for preventing colorectal cancer
EP0280737A4 (de)	1988-12-12	Steroidenheilmittelzubereitung zur äusserlichen verwendung.
ATE125445T1 (de)	1995-08-15	Orale zusammensetzung für die behandlung intestinaler entzündlicher krankheiten.
ES2130638T3 (es)	1999-07-01	Sistema para la liberacion de sustancia activa, filmogeno, vaporizable, para utilizar en las plantas.
EP0282316A3 (de)	1990-03-07	Schicht- oder Gelwundverband
JPS57171912A (en)	1982-10-22	Cream
CA2140545A1 (en)	1994-03-03	Use of first runnings coconut fatty acid as insect-repellent
SE9403158D0 (sv)	1994-09-21	New use of prostaglandins
IT1275556B (it)	1997-08-07	Procedimento ed impianto per la disidratazione di foraggio, particolarmente per la disidratazione dell'erba medica
FI896321A7 (fi)	1990-06-30	Aktiiviainetta sisältävät mikrorakeet, jotka koostuvat pääasiassa kyllästettyjen rasvahappojen triglyseridistä, ja niiden käyttö paikallisesti sairaanhoitoalalla
JPH10139676A5 (de)	2004-10-21
NZ336600A (en)	2000-07-28	Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation
ES2076543T3 (es)	1995-11-01	Extracto de kawa-kawa, procedimiento para su preparacion y su utilizacion.
RU99117143A (ru)	2001-06-10	Применение дихлорбензилового спирта для получения лекарственного средства для местного лечения воспаления и лекарственное средство, содержащее дихлорбензиловый спирт
JPS5562014A (en)	1980-05-10	Aqueous poultice having no skin irritation effect
AR230422A1 (es)	1984-04-30	Procedimiento para preparar el acido(2',4'-difluoro-4-bifenil)-oxipropionico de accion analgesica y anti-inflamatoria
CA2259270A1 (en)	1998-10-29	Pharmaceutical preparation containing nimesulide for oral administration